Mission
The mission of the Scleroderma Research Foundation is to fund and facilitate the most promising, highest quality research aimed at new treatments and, ultimately, a cure for scleroderma.
Scleroderma Research Foundation, of San Francisco, CA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $13.1M in revenue, $10.3M in expenses, $42.2M in total assets. 95 publicly reported grants to this organization, totaling roughly $5.0M, appear in IRS filings.
The mission of the Scleroderma Research Foundation is to fund and facilitate the most promising, highest quality research aimed at new treatments and, ultimately, a cure for scleroderma.
Showing up to 5 of 95 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $13.1M | $10.3M | $42.2M |
| 2024 | $12.2M | $9.6M | $33.0M |
| 2023 | $8.4M | $6.5M | $18.7M |
| 2022 | $5.9M | $4.7M | $11.1M |
| 2021 | $3.8M | $3.7M | $9.8M |
Between 2021 and 2025, reported annual revenue grew from $3.8M to $13.1M (+248%), with total assets most recently reported at $42.2M.
Interactive year-over-year charts and full filing details available with membership.